| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Alistair K Brown, Zhe Xia, Patrique Bulloch, Ifeoluwa Idowu, Olga Francisco, Jorg Stetefeld, Jake Stout, Jeff Zimmer, Chris Marvin, Robert J Letcher, Gregg Tom. Validated quantitative cannabis profiling for Canadian regulatory compliance - Cannabinoids, aflatoxins, and terpenes. Analytica chimica acta. vol 1088. 2020-02-17. PMID:31623719. |
validated quantitative cannabis profiling for canadian regulatory compliance - cannabinoids, aflatoxins, and terpenes. |
2020-02-17 |
2023-08-13 |
Not clear |
| Mohaddeseh Ebrahimi-Ghiri, Mohammad Nasehi, Mohammad-Reza Zarrindas. Anxiolytic and antidepressant effects of ACPA and harmaline co-treatment. Behavioural brain research. vol 364. 2020-02-13. PMID:30797851. |
because the psychotropic effects and abuse liability of cannabis prevent its therapeutic application in depression and anxiety states, we decided to investigate the effects of the combination of ineffective doses of cannabinoid cb1 receptor agonist arachidonylcyclopropylamide (acpa) and β-carbolines on anxiety- and depression-related behaviors in male nmri mice. |
2020-02-13 |
2023-08-13 |
mouse |
| Pedro Modesto Nascimento Menezes, Emanuella Chiara Valença Pereira, Maria Eduarda Gomes da Cruz Silva, Bismarques Augusto Oliveira da Silva, Luiz Antonio Miranda de Souza Duarte Filho, Tarcísio Cícero de Lima Araújo, Kátia Simoni Bezerra Lima, Fabrício Souza Silva, Larissa Araújo Roli. Cannabis and Cannabinoids on Treatment of Inflammation: A Patent Review. Recent patents on biotechnology. vol 13. issue 4. 2020-02-10. PMID:31237222. |
cannabis and cannabinoids on treatment of inflammation: a patent review. |
2020-02-10 |
2023-08-13 |
Not clear |
| Pedro Modesto Nascimento Menezes, Emanuella Chiara Valença Pereira, Maria Eduarda Gomes da Cruz Silva, Bismarques Augusto Oliveira da Silva, Luiz Antonio Miranda de Souza Duarte Filho, Tarcísio Cícero de Lima Araújo, Kátia Simoni Bezerra Lima, Fabrício Souza Silva, Larissa Araújo Roli. Cannabis and Cannabinoids on Treatment of Inflammation: A Patent Review. Recent patents on biotechnology. vol 13. issue 4. 2020-02-10. PMID:31237222. |
in this sense, herbal medicine and derivatives have gained more attention because of their effectiveness and safety, showing the importance of medicinal plants, especially the cannabis genus and the cannabinoid derivatives. |
2020-02-10 |
2023-08-13 |
Not clear |
| Koby Cohen, Abraham Weizman, Aviv Weinstei. Positive and Negative Effects of Cannabis and Cannabinoids on Health. Clinical pharmacology and therapeutics. vol 105. issue 5. 2020-02-07. PMID:30703255. |
positive and negative effects of cannabis and cannabinoids on health. |
2020-02-07 |
2023-08-13 |
Not clear |
| Zhiqiang Liu, Yi Xu, Xiaofan Zhang, Jinfeng Miao, Jing Han, Zhou Zh. Riluzole blocks HU210-facilitated ventral tegmental long-term depression by enhancing glutamate uptake in astrocytes. Neuroscience letters. vol 704. 2020-02-05. PMID:30978452. |
the lifetime prevalence of addiction to cannabis (marijuana or cannabinoids) is among the highest of that of all illicit drugs in developed countries, and no effective treatment for cannabis addiction is currently available. |
2020-02-05 |
2023-08-13 |
rat |
| Yuli Qian, Bill J Gurley, John S Markowit. The Potential for Pharmacokinetic Interactions Between Cannabis Products and Conventional Medications. Journal of clinical psychopharmacology. vol 39. issue 5. 2020-01-29. PMID:31433338. |
this review aims to identify drug-metabolizing enzymes and drug transporters that are affected by concurrent cannabis use and, conversely, those co-prescribed medications that may alter the exposure to one or more cannabinoids. |
2020-01-29 |
2023-08-13 |
Not clear |
| Luigia Cristino, Tiziana Bisogno, Vincenzo Di Marz. Cannabinoids and the expanded endocannabinoid system in neurological disorders. Nature reviews. Neurology. vol 16. issue 1. 2020-01-29. PMID:31831863. |
anecdotal evidence that cannabis preparations have medical benefits together with the discovery of the psychotropic plant cannabinoid Δ |
2020-01-29 |
2023-08-13 |
Not clear |
| Byungsuk Cho, Han Soo Cho, Junghyun Kim, Juhyun Sim, Ilung Seol, Seung Kyung Baeck, Sangwhan In, Dae Hwan Shin, Eunmi Ki. Simultaneous determination of synthetic cannabinoids and their metabolites in human hair using LC-MS/MS and application to human hair. Forensic science international. vol 306. 2020-01-28. PMID:31786516. |
synthetic cannabinoids are a class of chemicals that bind to cannabinoid receptors, but they differ structurally from the cannabinoids found in cannabis. |
2020-01-28 |
2023-08-13 |
human |
| Byungsuk Cho, Han Soo Cho, Junghyun Kim, Juhyun Sim, Ilung Seol, Seung Kyung Baeck, Sangwhan In, Dae Hwan Shin, Eunmi Ki. Simultaneous determination of synthetic cannabinoids and their metabolites in human hair using LC-MS/MS and application to human hair. Forensic science international. vol 306. 2020-01-28. PMID:31786516. |
unlike traditional drugs such as methamphetamine and cannabis, the abuse trends of synthetic cannabinoids were variable by regions and changed according to the times. |
2020-01-28 |
2023-08-13 |
human |
| Priyanka D Pinky, Jenna Bloemer, Warren D Smith, Timothy Moore, Hao Hong, Vishnu Suppiramaniam, Miranda N Ree. Prenatal cannabinoid exposure and altered neurotransmission. Neuropharmacology. vol 149. 2020-01-27. PMID:30771373. |
thus, exploration of neurotransmitter changes in response to prenatal cannabinoid exposure is crucial to develop an understanding of how homeostatic imbalance and various long-term neurobehavioral deficits manifest following the abuse of marijuana or other synthetic cannabinoids during pregnancy. |
2020-01-27 |
2023-08-13 |
human |
| Ganesh S Moorthy, Christina Vedar, Mary Ann DiLiberto, Athena F Zupp. A patient-centric liquid chromatography-tandem mass spectrometry microsampling assay for analysis of cannabinoids in human whole blood: Application to pediatric pharmacokinetic study. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences. vol 1130-1131. 2020-01-27. PMID:31670108. |
three major cannabinoids in cannabis are delta-9-tetrahydrocannabinol (thc), cannabidiol (cbd), and cannabinol (cbn). |
2020-01-27 |
2023-08-13 |
human |
| Nicola Black, Emily Stockings, Gabrielle Campbell, Lucy T Tran, Dino Zagic, Wayne D Hall, Michael Farrell, Louisa Degenhard. Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis. The lancet. Psychiatry. vol 6. issue 12. 2020-01-27. PMID:31672337. |
medicinal cannabinoids, including medicinal cannabis and pharmaceutical cannabinoids and their synthetic derivatives, such as tetrahydrocannabinol (thc) and cannabidiol (cbd), have been suggested to have a therapeutic role in certain mental disorders. |
2020-01-27 |
2023-08-13 |
Not clear |
| Jodi M Gilman, Meryem A Yücel, Gladys N Pachas, Kevin Potter, Nina Levar, Hannah Broos, Eve M Manghis, Randi M Schuster, A Eden Evin. Delta-9-tetrahydrocannabinol intoxication is associated with increased prefrontal activation as assessed with functional near-infrared spectroscopy: A report of a potential biomarker of intoxication. NeuroImage. vol 197. 2020-01-24. PMID:31075393. |
the primary psychoactive compound in cannabis, Δ9-tetrahydrocannabinol (thc), binds to cannabinoid receptors (cb1) present in high concentrations in the prefrontal cortex (pfc). |
2020-01-24 |
2023-08-13 |
human |
| Rocio Saravia, Marc Ten-Blanco, María T Grande, Rafael Maldonado, Fernando Berrender. Anti-inflammatory agents for smoking cessation? Focus on cognitive deficits associated with nicotine withdrawal in male mice. Brain, behavior, and immunity. vol 75. 2020-01-23. PMID:30391635. |
treatment with the non-psychoactive cannabinoid cannabidiol abolished memory impairment of nicotine withdrawal and microglia reactivity, reduced the expression of il1β and ifnγ in the hippocampus and the prefrontal cortex, respectively, and normalized ki67 levels. |
2020-01-23 |
2023-08-13 |
mouse |
| Tibor Stark, Jana Ruda-Kucerova, Fabio Arturo Iannotti, Claudio D'Addario, Roberta Di Marco, Vladimir Pekarik, Eva Drazanova, Fabiana Piscitelli, Monica Bari, Zuzana Babinska, Giovanni Giurdanella, Martina Di Bartolomeo, Salvatore Salomone, Alexandra Sulcova, Mauro Maccarrone, Carsten T Wotjak, Zenon Starcuk, Filippo Drago, Raphael Mechoulam, Vincenzo Di Marzo, Vincenzo Mical. Peripubertal cannabidiol treatment rescues behavioral and neurochemical abnormalities in the MAM model of schizophrenia. Neuropharmacology. vol 146. 2020-01-23. PMID:30496751. |
both the schizophrenia-like phenotype and altered transcriptional regulation of cb1 receptors were reversed by peripubertal treatment (from pnd 19 to pnd 39) with the non-psychotropic phytocannabinoid cannabidiol (30 mg/kg/day), or, in part, by treatment with the cannabinoid cb1 receptor antagonist/inverse agonist am251 (0.5 mg/kg/day), but not with haloperidol (0.6 mg/kg/day). |
2020-01-23 |
2023-08-13 |
rat |
| Yuli Qian, Xinwen Wang, John S Markowit. In Vitro Inhibition of Carboxylesterase 1 by Major Cannabinoids and Selected Metabolites. Drug metabolism and disposition: the biological fate of chemicals. vol 47. issue 5. 2020-01-23. PMID:30833288. |
in this study, we investigated the in vitro inhibitory effects of the individual major cannabinoids and metabolites ∆9-tetrahydrocannabinol (thc), cannabidiol (cbd), cannabinol (cbn), 11-nor-thc-carboxylic acid, and 11-hydroxy-thc on ces1 activity. |
2020-01-23 |
2023-08-13 |
human |
| I Hernández-Ramos, P Parra-Esquivel, Á López-Hernández, G Burillo-Putz. [Spontaneuos pneumomediastinum secondary to cannabinoid hyperemesis syndrome]. Anales del sistema sanitario de Navarra. vol 42. issue 2. 2020-01-23. PMID:31133765. |
cannabinoid hyperemesis syndrome (chs) is little known amongst clinicians and is characterised by abdominal pain and cyclical vomiting, after intense consumption of cannabis over several years. |
2020-01-23 |
2023-08-13 |
Not clear |
| Michael Kraemer, Sebastian Broecker, Burkhard Madea, Cornelius Hes. Decarbonylation: A metabolic pathway of cannabidiol in humans. Drug testing and analysis. vol 11. issue 7. 2020-01-21. PMID:30698361. |
cannabidiol (cbd) is a non-psychoactive cannabinoid, which is of growing medical interest. |
2020-01-21 |
2023-08-13 |
mouse |
| Marilyn A Huestis, Benjamin C Blount, Daniel F Milan, Matthew N Newmeyer, Jennifer Schroeder, Michael L Smit. Correlation of creatinine- and specific gravity-normalized free and glucuronidated urine cannabinoid concentrations following smoked, vaporized, and oral cannabis in frequent and occasional cannabis users. Drug testing and analysis. vol 11. issue 7. 2020-01-21. PMID:30756523. |
correlation of creatinine- and specific gravity-normalized free and glucuronidated urine cannabinoid concentrations following smoked, vaporized, and oral cannabis in frequent and occasional cannabis users. |
2020-01-21 |
2023-08-13 |
Not clear |